Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1989 1
1991 1
1993 1
1995 1
1996 1
2001 2
2002 3
2004 2
2007 1
2010 1
2012 2
2013 2
2014 1
2016 1
2018 1
2020 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group.
Judson I, Radford JA, Harris M, Blay JY, van Hoesel Q, le Cesne A, van Oosterom AT, Clemons MJ, Kamby C, Hermans C, Whittaker J, Donato di Paola E, Verweij J, Nielsen S. Judson I, et al. Among authors: donato di paola e. Eur J Cancer. 2001 May;37(7):870-7. doi: 10.1016/s0959-8049(01)00050-8. Eur J Cancer. 2001. PMID: 11313175 Clinical Trial.
It's time for chronotherapy!
Coudert B, Focan C, Donato di Paola E, Lévi F; EORTC Chronotherapy Group. Coudert B, et al. Among authors: donato di paola e. Eur J Cancer. 2002 Mar;38 Suppl 4:S50-3. doi: 10.1016/s0959-8049(01)00447-6. Eur J Cancer. 2002. PMID: 11858965
Efficacy and safety of bevacizumab in glioblastomas.
De Fazio S, Russo E, Ammendola M, Donato Di Paola E, De Sarro G. De Fazio S, et al. Among authors: donato di paola e. Curr Med Chem. 2012;19(7):972-81. doi: 10.2174/092986712799320646. Curr Med Chem. 2012. PMID: 22214463 Review.
Safety profile of biologic drugs for psoriasis in clinical practice: An Italian prospective pharmacovigilance study.
Iannone LF, Bennardo L, Palleria C, Roberti R, De Sarro C, Naturale MD, Dastoli S, Donato L, Manti A, Valenti G, D'Amico D, D'Attola S, De Francesco AE, Bosco V, Donato Di Paola E, Nisticò SP, Citraro R, Russo E, De Sarro G. Iannone LF, et al. Among authors: donato di paola e. PLoS One. 2020 Nov 3;15(11):e0241575. doi: 10.1371/journal.pone.0241575. eCollection 2020. PLoS One. 2020. PMID: 33141869 Free PMC article.
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy.
Roberti R, Iannone LF, Palleria C, De Sarro C, Spagnuolo R, Barbieri MA, Vero A, Manti A, Pisana V, Fries W, Trifirò G, Naturale MD, Larussa T, De Francesco AE, Bosco V, Donato di Paola E, Citraro R, Luzza F, Bennardo L, Rodinò S, Doldo P, Spina E, Russo E, De Sarro G. Roberti R, et al. Among authors: donato di paola e. Curr Med Res Opin. 2020 Sep;36(9):1457-1463. doi: 10.1080/03007995.2020.1786681. Epub 2020 Jul 27. Curr Med Res Opin. 2020. PMID: 32573307
Novel 3-carboxy- and 3-phosphonopyrazoline amino acids as potent and selective NMDA receptor antagonists: design, synthesis, and pharmacological characterization.
Conti P, Pinto A, Tamborini L, Madsen U, Nielsen B, Bräuner-Osborne H, Hansen KB, Landucci E, Pellegrini-Giampietro DE, De Sarro G, Donato Di Paola E, De Micheli C. Conti P, et al. Among authors: donato di paola e. ChemMedChem. 2010 Sep 3;5(9):1465-75. doi: 10.1002/cmdc.201000184. ChemMedChem. 2010. PMID: 20665761
22 results